N/A
Manufactured by Wal-Mart Stores, Inc.
32 FDA adverse event reports analyzed
Last updated: 2026-04-15
POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Wal-Mart Stores, Inc.. The most commonly reported adverse reactions for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL include CATARACT, DERMATITIS ATOPIC, DYSPEPSIA, DYSPHAGIA, GASTROENTERITIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL.
Out of 7 classified reports for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 32 FDA FAERS reports that mention POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include CATARACT, DERMATITIS ATOPIC, DYSPEPSIA, DYSPHAGIA, GASTROENTERITIS, ATRIAL FIBRILLATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Wal-Mart Stores, Inc. in connection with POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL. Always verify the specific product and NDC with your pharmacist.